A rational basis for mucosal vaccination against HIV infection.
about
Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.Human peripheral blood T cells, monocytes, and macrophages secrete macrophage inflammatory proteins 1alpha and 1beta following stimulation with heat-inactivated Brucella abortus.Strategies for designing and optimizing new generation vaccines.Oral mucosal immunity and HIV infection: current status.The role of immunity in protection from mucosal SIV infection in macaques.Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa.Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus.Rotavirus enterotoxin NSP4 has mucosal adjuvant properties.Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virusMucosal and Systemic Immune Responses to Influenza H7N9 Antigen HA1-2 Co-Delivered Intranasally with Flagellin or Polyethyleneimine in Mice and Chickens.Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodesImmunity in the female lower genital tract and the impact of HIV infection.
P2860
Q33854138-E9CF161A-6943-4A97-9D55-2EA477427559Q34007794-ECF998EE-4DF4-45FE-957F-27FBE313F917Q34572198-9A806F34-1330-4899-B3EC-77E9BCD000BBQ34775263-61F01960-2E05-446D-A347-1330B886B52DQ34775270-E63D019C-5D91-4AB1-BB46-D08EEDD312CAQ35575565-D11C2059-8A06-4C7B-8255-89C64E402DDEQ35849596-EC9F4E37-9A0B-4B9F-A7DA-7176F07894C0Q36464982-330D6489-00CC-4097-A95A-9291205C3F8AQ36853450-F1DE9145-C035-4720-93FB-2AFB4ED8EC2AQ36873521-C5C68752-CF8E-4ED7-8CE7-CB216054B579Q36943971-88B053C5-2E7B-4641-8AEF-6E4800B99609Q37737532-B1B08362-EFCC-4449-9480-1A0D30727D10Q39169078-9F49B49B-CA68-4246-9578-3DEC2ECC31DBQ39756926-D348B2A6-D84E-4846-882D-9F503159B8A2Q44212305-A3FA3BD3-FB62-4983-B358-99629505E4D9
P2860
A rational basis for mucosal vaccination against HIV infection.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A rational basis for mucosal vaccination against HIV infection.
@ast
A rational basis for mucosal vaccination against HIV infection.
@en
type
label
A rational basis for mucosal vaccination against HIV infection.
@ast
A rational basis for mucosal vaccination against HIV infection.
@en
prefLabel
A rational basis for mucosal vaccination against HIV infection.
@ast
A rational basis for mucosal vaccination against HIV infection.
@en
P2093
P2860
P1476
A rational basis for mucosal vaccination against HIV infection.
@en
P2093
P2860
P304
P356
10.1111/J.1600-065X.1999.TB01338.X
P577
1999-08-01T00:00:00Z